Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 1 - Micro-organisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving micro-organisms or compositions thereof; Processes of preparing or isolating a composition containing a micro-organism; Culture media therefor
Patents for C12N 1 - Micro-organisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving micro-organisms or compositions thereof; Processes of preparing or isolating a composition containing a micro-organism; Culture media therefor (148,866)
10/2003
10/23/2003WO2003087123A2 Methods and kits for testing mutagenicity
10/23/2003WO2003086446A1 Monomeric and dimeric fluorescent protein variants and methods for making same
10/23/2003WO2003086277A2 Attenuated gram negative bacteria
10/23/2003WO2003086175A2 Compositions and methods for the therapy and diagnosis of lung cancer
10/23/2003WO2003057898A3 Methods and materials for modulating p2x2
10/23/2003WO2003057252A8 Human mast cell-expressed membrane proteins
10/23/2003WO2003055998A3 Process for the preparation of a beta-lactam antibiotic with mutated penicillin acylase
10/23/2003WO2003054193A3 Raf/ras binding compounds
10/23/2003WO2003051124A3 Inhibition of the asexual reproduction of fungi
10/23/2003WO2003040289A3 Genes coding for dna replication proteins and for proteins related to pathogenesis
10/23/2003WO2003023032A3 High throughput directed evolution by rational mutagenesis
10/23/2003WO2003016466A3 ANTI-Aβ ANTIBODIES
10/23/2003WO2003010201A3 Blood group antigen fusion polypeptides and methods of use thereof
10/23/2003WO2003006630A3 Nucleic acid free ghost preparations
10/23/2003WO2002094181B1 Gram-positive fatty acid degrader
10/23/2003WO2002089742A3 Heparin/heparosan synthase and methods of making and using same
10/23/2003WO2002081519A3 Ifn-thy fusion protein,dna coding therefore,its preparation and application
10/23/2003WO2002079395A3 Carotenoid biosynthesis
10/23/2003WO2002077216A3 Ikk2 variant, dino gene, lectin-like receptor gene, and proteins encoded thereby
10/23/2003WO2002072759A3 Method to screen peptide display libraries using minicell display
10/23/2003WO2002070712A3 Chitin deacetylase and method for producing the same
10/23/2003WO2002068589A3 Enzymes having alpha amylase activity and methods of use thereof
10/23/2003WO2002066494A8 Identification and cloning of a novel human gene, ret16, involved in the intracellular signaling cascade
10/23/2003WO2002062380A3 Chlamydia vaccine composition
10/23/2003WO2002055700A3 Human genes and gene expression products isolated from human prostate
10/23/2003WO2002046384A3 Kinases and phosphatases sequences, and use thereof
10/23/2003WO2002044336B1 Method of making a protein polymer and uses of the polymer
10/23/2003WO2002044321A3 Rna interference mediating small rna molecules
10/23/2003WO2002036806A3 Expression vectors able to elicit improved immune response and methods of using same
10/23/2003WO2001096376A9 Pro-apoptotic fragments of the dengue virus envelope glycoproteins
10/23/2003WO2001068805A3 Human olfactory receptors and genes encoding same
10/23/2003WO2001062944A3 Intergenic and intragenic integration sites for foreign gene expression in recombinant s. gordonii strains
10/23/2003WO2001055337A9 Methods and materials relating to carcinoembryonic antigen-like (cea-like) polypeptides and polynucleotides
10/23/2003WO2001000812A8 22012, a novel human carboxypeptidase
10/23/2003US20030199103 Novel amino acid sequences for human epidermal growth factor-like polypeptides
10/23/2003US20030199088 Minicell-based gene therapy
10/23/2003US20030199076 Composition for cell-free protein synthesis
10/23/2003US20030199075 Compactin is provided and contacted with Actinomadura bacteria containing hydroxylase under hydroxylation condition to convert compactin to pravastatin, useful for lowering cholesterol levels in mammals
10/23/2003US20030199068 High throughput mutagenesis screening method
10/23/2003US20030199067 Growth arrest homeobox gene
10/23/2003US20030199050 Supplying a suspension of cells in a treatment volume, which includes two electrodes in fluid contact with the suspension, applying a time varying bipolar electric potential across the electrode creating an electric field to porate the cell(s)
10/23/2003US20030199048 Polypeptides, capable of stereoselective hydrolysis of chiral feruloyl ester into ferulic acid and an alcohol
10/23/2003US20030199045 Process for the preparation of L-amino acids with amplification of the zwf gene
10/23/2003US20030199043 Therapeutic proteins (including polypeptide, antibody, peptide or fragment or variants)fused to albumin or fragment or variant linked by a linker peptide; nonglycosylated
10/23/2003US20030199042 Novel morphogenic protein
10/23/2003US20030199035 Metabolically engineered lactic acid bacteria and means for providing same
10/23/2003US20030199012 A nucleic acid construct having a nucleic acid molecule that encodes a factor suppressing an immune response to Mycobacterium tuberculosis in a host cell
10/23/2003US20030199005 Solid supports with minicells
10/23/2003US20030198996 Production of achromosomal and anucleate cells useful for diagnositic and therapeutic uses, as well as research tools and agents for drug discovery
10/23/2003US20030198995 Production of achromosomal and anucleate cells useful for diagnostic and therapeutic uses, as well as research tools and agents for drug discovery
10/23/2003US20030198991 Nucleotide sequences coding for the ptsI protein
10/23/2003US20030198981 Genes and proteins involved in the biosynthesis of lipopeptides
10/23/2003US20030198978 Thermus brockianus nucleic acid polymerases
10/23/2003US20030198975 Proteins associated with cell growth, differentiation, and death
10/23/2003US20030198955 Novel proteins and nucleic acids encoding same
10/23/2003US20030198953 For diagnosis, treatment, and prevention of related disorders
10/23/2003US20030198944 Compositions and methods for reverse transcription of nucleic acid molecules
10/23/2003US20030198681 Method of making a protein polymer and uses of the polymer
10/23/2003US20030198621 Polynucleotides encoding antigenic HIV type B and/or type C polypeptides, polypeptides and uses thereof
10/23/2003US20030198596 Genetic engineered plasmids; diagnosis glandular disorders
10/23/2003CA2853267A1 Automated tissue engineering system comprising sensors linked to a microprocessor
10/23/2003CA2849556A1 Preservation of bioactive materials by freeze dried foam
10/23/2003CA2521946A1 Method of identifying transmembrane protein-interacting compounds
10/23/2003CA2482718A1 Derivatives of the il-2 receptor gamma chain, their production and use
10/23/2003CA2482438A1 Plant acyl-coa synthetases
10/23/2003CA2482387A1 Derivatives of the nf-kappab inducing enzyme, their preparation and use
10/23/2003CA2481827A1 Polyvalent cation-sensing receptor in atlantic salmon
10/23/2003CA2481761A1 Methods for producing sulphurous fine chemicals by fermentation using meth-coding coryneform bacteria
10/23/2003CA2481509A1 Her-2 receptor tyrosine kinase molecules and uses thereof
10/23/2003CA2481508A1 G-protein coupled receptor ligands and methods
10/23/2003CA2481349A1 Peptides for detection of antibody to a. phagocytophilum
10/23/2003CA2481328A1 Monomeric and dimeric fluorescent protein variants and methods for making same
10/23/2003CA2481186A1 Attenuated gram negative bacteria
10/23/2003CA2474486A1 Targeted chromosomal mutagenesis using zinc finger nucleases
10/22/2003EP1354957A1 Process for producing coenzyme q 10
10/22/2003EP1354956A1 Process for producing prenyl alcohol
10/22/2003EP1354955A1 Process for producing prenyl alcohol
10/22/2003EP1354954A1 Process for producing prenyl alcohol
10/22/2003EP1354951A1 Method of examining ability to control nerve cell plasticity
10/22/2003EP1354950A1 Nf-kb activating gene
10/22/2003EP1354946A1 Bhlh-pas proteins, genes thereof and utilization of the same
10/22/2003EP1354940A2 Process and apparatus for conversion of biodegradable organic materials into product gas
10/22/2003EP1354891A1 Medicament comprising NK4 gene or recombinant NK4 protein
10/22/2003EP1354890A1 Novel polypeptide and dna thereof
10/22/2003EP1354889A1 Trasncription activation complex and utilization thereof
10/22/2003EP1354600A1 Antibody combination useful for tumor therapy
10/22/2003EP1354598A2 Therapeutic uses of BR43X2 soluble receptors
10/22/2003EP1354592A1 Medicines for relieving intestinal disorders
10/22/2003EP1354204A2 Hcv antigen/antibody combination assay
10/22/2003EP1354056A2 Enhanced secretion of a polypeptide by a microorganism
10/22/2003EP1354052A2 Dna sequence from kluyveromyces marxianus comprising regulatory regions for expressing proteins
10/22/2003EP1354048A2 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof
10/22/2003EP1354047A2 Methods for screening compounds that modulate lipid metabolism
10/22/2003EP1354046A2 A member of the lysyl oxidase gene family
10/22/2003EP1354043A2 Sequences involved in phenomena of tumour suppression, tumour reversion, apoptosis and/or virus resistance and their use as medicines
10/22/2003EP1354042A2 Proteins and nucleic acids encoding same
10/22/2003EP1354041A2 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
10/22/2003EP1354040A2 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/22/2003EP1354039A2 Atp-binding cassette transporter-like molecules and uses thereof
10/22/2003EP1354035A1 Methods and means for producing efficient silencing construct using recombinational cloning
1 ... 886 887 888 889 890 891 892 893 894 895 896 897 898 899 900 901 902 903 904 905 906 ... 1489